Overview
Proximal symphalangism (SYM1), also known as Cushing's symphalangism or hereditary symphalangism, is a rare genetic skeletal disorder characterized by bony fusion (ankylosis) of the proximal interphalangeal (PIP) joints of the fingers and, in some cases, the toes. The condition results from failure of normal joint formation during embryonic development. Affected individuals typically present with stiff, straight fingers due to the absence of functional proximal interphalangeal joints, with the ring and little fingers most commonly involved. The hands may appear relatively normal externally, but the inability to bend the affected joints leads to reduced grip strength and impaired fine motor function. In addition to the hand involvement, proximal symphalangism frequently affects other joints and structures. Conductive hearing loss is a common associated feature, resulting from fusion of the ossicles (small bones) in the middle ear, particularly the stapes. Some patients may also have fusion of carpal (wrist) or tarsal (ankle) bones. The condition is caused by heterozygous mutations in the NOG gene (encoding noggin) on chromosome 17q22 or, less commonly, in the GDF5 gene. Proximal symphalangism is allelic with multiple synostoses syndrome, representing a milder end of the same phenotypic spectrum. There is no cure for proximal symphalangism. Management is primarily supportive and symptomatic. Hearing aids may be beneficial for individuals with conductive hearing loss, and surgical intervention on the middle ear ossicles has been attempted in some cases. Occupational therapy can help optimize hand function. Surgical attempts to restore joint mobility in the fingers have generally been unsuccessful due to the fundamental absence of joint structures. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern with high penetrance but variable expressivity.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Proximal symphalangism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Proximal symphalangism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Proximal symphalangism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Proximal symphalangism.
Community
No community posts yet. Be the first to share your experience with Proximal symphalangism.
Start the conversation →Latest news about Proximal symphalangism
No recent news articles for Proximal symphalangism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Proximal symphalangism
What is Proximal symphalangism?
Proximal symphalangism (SYM1), also known as Cushing's symphalangism or hereditary symphalangism, is a rare genetic skeletal disorder characterized by bony fusion (ankylosis) of the proximal interphalangeal (PIP) joints of the fingers and, in some cases, the toes. The condition results from failure of normal joint formation during embryonic development. Affected individuals typically present with stiff, straight fingers due to the absence of functional proximal interphalangeal joints, with the ring and little fingers most commonly involved. The hands may appear relatively normal externally, bu
How is Proximal symphalangism inherited?
Proximal symphalangism follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Proximal symphalangism typically begin?
Typical onset of Proximal symphalangism is neonatal. Age of onset can vary across affected individuals.